These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7491445)

  • 21. [The antiproteinuric action of angiotensin-converting enzyme inhibitors in chronic glomerulonephritis and diabetic nephropathy].
    Kutyrina IM; Tareeva IE; Shestakova MV; Gerasimenko OI; Zverev KV; Rogov VA; Sheremet'eva OV
    Ter Arkh; 1994; 66(6):19-22. PubMed ID: 7940357
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Interview with the author of ELITE II. Cave: small studies of fatal illnesses].
    Pitt B
    MMW Fortschr Med; 1999 Nov; 141(47):6. PubMed ID: 10912156
    [No Abstract]   [Full Text] [Related]  

  • 23. ACE inhibitors versus angiotensin receptor blockers in diabetic nephropathy: is there a winner?
    Lewis EJ; Lewis JB
    J Am Soc Nephrol; 2004 May; 15(5):1358-60. PubMed ID: 15100380
    [No Abstract]   [Full Text] [Related]  

  • 24. Angiotensin converting enzyme inhibition in diabetic nephropathy. The Collaborative Study Group.
    Breyer JA; Hunsicker LG; Bain RP; Lewis EJ
    Kidney Int Suppl; 1994 Feb; 45():S156-60. PubMed ID: 8158886
    [No Abstract]   [Full Text] [Related]  

  • 25. [The ELITE 2 study].
    Mahé I
    Presse Med; 2000 Sep; 29(25):1407. PubMed ID: 11036516
    [No Abstract]   [Full Text] [Related]  

  • 26. The antiproteinuric effect of antihypertensive agents in diabetic nephropathy.
    Gansevoort RT; Apperloo AJ; Heeg JE; de Jong PE; de Zeeuw D
    Arch Intern Med; 1992 Oct; 152(10):2137-9. PubMed ID: 1417388
    [No Abstract]   [Full Text] [Related]  

  • 27. [The antianginal activity of angiotensin-converting enzyme inhibitors].
    Cherevatov BG; Shelest AN
    Lik Sprava; 1997; (5):50-3. PubMed ID: 9491696
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Therapy of diabetic nephropathy].
    Barna I
    Orv Hetil; 2003 Jan; 144(4):165-72. PubMed ID: 12621814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Specificity of drug therapy of hypertension in patients with diabetes mellitus].
    Tatoń J
    Pol Tyg Lek; 1988 Dec 19-26; 43(51-52):1661-7. PubMed ID: 3268820
    [No Abstract]   [Full Text] [Related]  

  • 30. A comprehensive review of antihypertensive agents providing renal protection.
    Kalus JS; White CM
    Conn Med; 2001 Oct; 65(10):587-91. PubMed ID: 11702517
    [No Abstract]   [Full Text] [Related]  

  • 31. [Antihypertensive efficacy, tolerance and safety of lisinopril (sinopril) and captopril (capoten) in patients with mild and moderate arterial hypertension].
    Ol'binskaia LI; Sizova ZhM; Zheleznykh EA; Fitilev SB; Sergeeva TE; Pukhlianko ME; Potapova GN
    Ter Arkh; 1999; 71(11):61-4. PubMed ID: 10626341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiotensin II type 1 receptor blockers and congestive heart failure.
    Auer JW; Berent R; Eber B
    Circulation; 2001 Oct; 104(15):E82. PubMed ID: 11591633
    [No Abstract]   [Full Text] [Related]  

  • 33. [Renal effects of angiotensin-converting enzyme inhibitors and their therapeutic use in chronic terminal renal failure].
    Ritz E; Mann JF; Rambausek M
    Z Kardiol; 1988; 77 Suppl 3():57-60. PubMed ID: 2850688
    [No Abstract]   [Full Text] [Related]  

  • 34. Tissue levels, tissue angiotensin converting enzyme inhibition and antihypertensive effect of the novel antihypertensive agent alacepril in renal hypertensive rats.
    Nambu K; Matsumoto K; Takeyama K; Hosoki K; Miyazaki H; Hashimoto M
    Arzneimittelforschung; 1986; 36(1):47-51. PubMed ID: 3006710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of different antihypertensive drugs on human diabetic proteinuria.
    Weidmann P; Boehlen LM; de Courten M
    Nephrol Dial Transplant; 1993; 8(7):582-4. PubMed ID: 8396739
    [No Abstract]   [Full Text] [Related]  

  • 36. Captopril, an orally active angiotensin I converting enzyme inhibitor in the treatment of renovascular and essential hypertension.
    Holtzman E; Rosenthal T; Stern N; Knecht A; Yaron A
    Isr J Med Sci; 1982 May; 18(5):597-602. PubMed ID: 6284678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypotensive mechanisms of captopril--a counter-view.
    Lazar AI
    J Assoc Physicians India; 1996 Oct; 44(10):753. PubMed ID: 9251364
    [No Abstract]   [Full Text] [Related]  

  • 38. Using ACE inhibitors appropriately.
    Bicket DP
    Am Fam Physician; 2002 Aug; 66(3):461-8. PubMed ID: 12182524
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of captopril in rheumatoid arthritis: combining treatment targets!
    Popa CD; van Riel PL
    Can J Cardiol; 2013 May; 29(5):639.e13. PubMed ID: 23541661
    [No Abstract]   [Full Text] [Related]  

  • 40. Indapamide is as effective as captopril in the control of microalbuminuria in diabetes.
    Molyneaux LM; Willey KA; Yue DK
    J Cardiovasc Pharmacol; 1996 Mar; 27(3):424-7. PubMed ID: 8907805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.